Galecto Inc (GLTO)
Official siteBIOTECHNOLOGY
Last updated: Nov 13, 2026 at 4:00 PM ET
Earnings
Performance (10Y)
Key Metrics
Technical Indicators Dashboard
As of Nov 16, 2026, the price is 2.7% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 46.8, in the neutral range between 30 and 70.
Moving Averages
MACD
ADX
Aroon & PSAR
Bollinger Bands
RSI (14-Day)
Momentum Oscillators
Volatility Measures
Volume Flow
Volume Metrics
Pivot Points
Advanced Oscillators
Financial Performance
Related GNG Research
No research available
Be the first to write about GLTO
News
No news available
Company news will appear here when available
GLTO Valuation
- P/FCF
- -2.3x
- P/B
- 4.3x
GLTO Profitability: Margins, ROIC and FCF
- FCF yield
- -42.7%
Galecto Competitors
Peers by sector and size for Galecto (GLTO) include Sangamo Therapeutics, Evoke Pharma and Pelthos Therapeutics.
Sector: Healthcare
GLTO Bull Case vs Bear Case
Bull case
- GLTO beat EPS estimates in 87.5% of its last 8 reported quarters.
GLTO Earnings: Beat Rate
- Beat rate
- 7 of 8 quarters (87.5%)
- Average surprise
- 17.2%
GLTO ETF Holders
GNG tracks 1 ETF that holds GLTO.
- Vanguard Extended Market Index Fund ETF Shares (VXF), <0.01% of the fund
Updated Nov 20, 2025. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology
Frequently Asked Questions About GLTO
Does GLTO pay dividends?
Galecto Inc (GLTO) does not currently pay a regular dividend.
GLTO pages: Overview, Financials
Get full access to GNG Research
Create a free account to access portfolio tracking, advanced tools, and more.